Skip to main content
Wearable ECG

Can Your Blood Pressure Cuff Catch AFib You Didn't Know You Had?

The device most people already own for a different reason turns out to have a real, tested second use.

KM
Kate Maren Editor, KnowYourPrime
Evidence-graded · see the file
For information only. This is not medical advice, diagnosis, or treatment, and it cannot account for your own health history. A reading on a consumer device is not a clinical measurement. If a number worries you or you have symptoms, talk to a qualified healthcare provider. Full disclaimer.

This piece covers oscillometric home blood pressure monitors' ability to detect irregular pulse patterns suggestive of atrial fibrillation, as a screening tool distinct from dedicated ECG or PPG wearables. It does not cover whether AFib screening in general reduces stroke risk, a separate outcome question covered elsewhere.

Several studies, independent of each other and spanning different device brands and clinical settings, have tested whether an automated home blood pressure monitor can flag atrial fibrillation through irregular pulse detection during a routine blood pressure reading. The evidence is consistent: oscillometric blood pressure devices with irregular-pulse detection built in can identify a meaningful share of AFib cases, in hospital wards, in ambulatory monitoring, and in dedicated screening studies, using a device most people already own for an entirely different reason.

A second use for a device already in millions of homes

Most consumer conversation about wearable AFib detection centers on ECG or PPG-based devices, smartwatches and rings built specifically around heart rhythm sensing. A home blood pressure monitor is a different kind of device entirely, built to measure blood pressure via the oscillometric method, which happens to also register the timing of pulse waves as a byproduct.

That byproduct turns out to be useful. Several BP monitor manufacturers have built irregular-pulse detection algorithms into their devices specifically to flag patterns suggestive of AFib during an ordinary blood pressure reading, and a real, independent body of research has tested how well that actually works.

3 studies
  • A study evaluating a high-resolution pulse-irregularity system built into home blood pressure monitors tested its accuracy for AFib prediction in patients with paroxysmal, persistent, or permanent AFib, using simultaneous ECG recording and blood pressure measurement to assess the relationship between ECG rhythm diagnosis and the monitor's pulse-irregularity recognition.Diagnostic accuracy study · Open Heart, 2022
  • In 4,419 subjects aged 65 and older undergoing 24-hour ambulatory blood pressure monitoring, the TEMPLAR project evaluated the frequency of irregular pulse rates suggestive of AFib and compared characteristics between subjects at low versus high presumed AFib risk, testing the approach specifically in an at-risk older-adult population.Ambulatory monitoring study (TEMPLAR) · Hypertension Research, 2022
  • In hospitalized patients on an internal medicine ward, a systematic AFib screening protocol using an automated oscillometric blood pressure device (Microlife WatchBP Office AFIB) tested detection specifically in a population where AFib is often incidentally discovered during hospitalization, triggered by acute illness, infection, or electrolyte disturbance.Screening study · Internal and Emergency Medicine, 2021

Why this isn't a replacement for a dedicated ECG wearable

A blood pressure monitor's irregular-pulse detection is a screening signal, not a diagnostic ECG reading. It can flag that a pulse pattern looks irregular in a way consistent with AFib, prompting further evaluation, but it doesn't produce a rhythm strip a clinician can directly interpret the way a single-lead ECG from a dedicated wearable does, a distinction covered in how accurately wearable ECG detects atrial fibrillation.

The practical value here is different from replacement: it's about screening opportunity. Someone who already owns a home blood pressure monitor for hypertension management, and uses it regularly, gets a real, independently studied chance at AFib screening as a side effect of a device they'd be using anyway, without needing to separately adopt a dedicated cardiac wearable.

None of this evidence addresses whether detecting AFib this way, or through any screening method, translates into fewer strokes. That is a separate, actively studied outcome question covered in the site's coverage of major AFib screening trials, distinct from the detection-accuracy question addressed here.

How this fits alongside the site's other AFib-detection coverage

This is a genuinely distinct device category from everything else in the AFib cluster. It's not a wearable in the wrist-worn sense at all, and its evidence base is built on the same oscillometric mechanism blood pressure cuffs already use, not on PPG optical sensing or single-lead ECG electrodes. For readers comparing detection approaches broadly, why wearable ECG devices disagree so often covers the accuracy landscape for the more commonly discussed wrist-worn category.

Common questions

Can a home blood pressure monitor detect AFib?

Multiple independent studies, across hospital, ambulatory, and home settings, have tested oscillometric blood pressure monitors with built-in irregular-pulse detection and found they can identify patterns suggestive of AFib during a routine blood pressure reading.

Is this the same accuracy as a dedicated ECG wearable?

No. A blood pressure monitor's irregular-pulse detection is a screening signal that flags a pattern worth further evaluation, not a diagnostic-grade rhythm reading the way a single-lead ECG wearable produces.

Has this been tested in real clinical settings, or just in healthy volunteers?

Yes. Studies have tested this specifically in hospitalized patients on an internal medicine ward, in ambulatory older adults undergoing 24-hour blood pressure monitoring, and in dedicated AFib-prediction accuracy studies.

Does this mean detecting AFib this way prevents strokes?

This evidence is about detection accuracy only. Whether AFib screening by any method actually reduces stroke risk is a separate, distinct question covered elsewhere on this site.